     |
| About NicOx | |||
| Products | |||
|
Naproxcinod NCX 6560 Full portfolio |
|||
| Maximizing portfolio | |||
| Co-development Research alliances Technology |
|||
| People | |||
| Board
of Directors Management Team Contacts Careers |
|||
| Investor & media | |||
| Press
releases Investor relations Fact file Financials Corporate governance "Informations Réglementées" Conferences |
|||
| Home | |||
| Directions
to NicOx Site en français |
|||
 |
NicOx Executive Management Team | ||
|
Michele GARUFI | Chairman and CEO | |
|
Maarten BEEKMAN | Vice President, Clinical Development & Medical Affairs | |
| Eric CASTALDI | Chief Financial Officer | ||
| Jacques DJIAN | Vice President, Exploratory Development & Translational Medicine | ||
|
Ennio ONGINI | Vice President, Research | |
| Pascal PFISTER | Chief Scientific Officer | ||
| Elizabeth ROBINSON | President of the NicOx Research Institute Srl | ||
|
Philippe SERRANO | Vice President, Regulatory Affairs | |
| Sanjiv SHARMA | Vice President, Commercial | ||
| Gavin SPENCER | Vice President, Business Development | ||
|
|||